These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6673029)

  • 1. [Erythrocyte filterability and treatment with pentoxifylline].
    Valentini M; Sciannameo F; Francucci M; Tockner M; Sassano L; Allegra A
    Ric Clin Lab; 1983; 13 Suppl 3():455-8. PubMed ID: 6673029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients.
    Ferrari E; Fioravanti M; Patti AL; Viola C; Solerte SB
    Pharmatherapeutica; 1987; 5(1):26-39. PubMed ID: 3602021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on relationship between erythrocyte filtration and other risk factors in diabetic angiopathy.
    Pozza G; Cordaro C; Carandente O; Margonato A
    Ric Clin Lab; 1981; 11 Suppl 1():317-26. PubMed ID: 7188119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of erythrocyte filtration in the study of diabetic vasculopathy. Therapeutic efficacy of pentoxifylline].
    Moratti F; Cortiana M; Taglioretti D
    Clin Ter; 1983 Jul; 106(1):19-25. PubMed ID: 6627879
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pentoxifylline and arterial hypertension in diabetes mellitus: long-term results in randomized groups].
    Solerte SB; Adamo S; Viola C; Zambianchi E; Ferrari E
    Ric Clin Lab; 1985; 15 Suppl 1():515-26. PubMed ID: 4035232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Trental treatment of microcirculatory disorders in diabetes mellitus and arteriosclerosis].
    Vogralik VG; Vogralik MV; Runov GP; Runova AA; Kostrov AI
    Klin Med (Mosk); 1982 Oct; 60(10):90-4. PubMed ID: 7176484
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability].
    Pilla G; Ciaponi A; Migliavacca A; Bonora C
    Ric Clin Lab; 1983; 13 Suppl 3():459-64. PubMed ID: 6324325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of pentoxifylline in diabetes with intermittent claudication].
    Petruzzi E; Bucalossi A; Corri S; Marsilii A; Di Noto C
    Ric Clin Lab; 1983; 13 Suppl 3():451-4. PubMed ID: 6673028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic effect of Trental in diabetic angiopathy].
    Pampulov L; Kolarov P; Veleva N
    Vutr Boles; 1978; 17(2):66-72. PubMed ID: 349882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of clinical, laboratory and haemorheological investigations of the use of pentoxifylline in high doses.
    Antignani PL; Todini AR; Saliceti F; Pacino G; Bartolo M
    Pharmatherapeutica; 1987; 5(1):50-6. PubMed ID: 3602022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical considerations and treatment of diabetic angiopathy.
    Nobbe F
    J Med; 1979; 10(5):365-79. PubMed ID: 393791
    [No Abstract]   [Full Text] [Related]  

  • 12. Study of the erythrocyte deformability in juvenile onset diabetes.
    Marigo S; Foce S; Canova G; Torniai E; Del Nevo G
    Ric Clin Lab; 1981; 11 Suppl 1():313-6. PubMed ID: 7188118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of trental and complamine in the microcirculatory disorders of diabetes mellitus].
    Spesivtseva VG; Kasabian IN; Mamaeva GG; Kukes VG
    Sov Med; 1980; (2):64-9. PubMed ID: 6987747
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetic retinal vascular complications and erythrocyte filtrability; results of a 2-year follow-up study with pentoxifylline.
    Solerte SB; Ferrari E
    Pharmatherapeutica; 1985; 4(6):341-50. PubMed ID: 4080752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetes and heterozygotic sickle-cell anemia: study of erythrocyte deformability].
    Abadie E; Fisch A
    Pathol Biol (Paris); 1984 Apr; 32(4):256-9. PubMed ID: 6718066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of haemorheological factors in the ageing brain: long-term therapy with pentoxifylline ('Trental' 400) in elderly patients with initial mental deterioration.
    Parnetti L; Ciuffetti G; Mercuri M; Lupattelli G; Senin U
    Pharmatherapeutica; 1986; 4(10):617-27. PubMed ID: 3602014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic results with xanthine derivatives in the intermittent claudication syndrome in diabetic patients].
    Gómez Reyes D; Rojas Hidalgo E
    Rev Clin Esp; 1988 Jan; 182(1):3-6. PubMed ID: 3375512
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of pentoxifylline on erythrocyte deformability and on phosphatide fatty acid distribution in the erythrocyte membrane.
    Schubotz R; Mühlfellner O
    Curr Med Res Opin; 1977; 4(9):609-17. PubMed ID: 590022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of Trental in the treatment of arterial and venous circulation disorders].
    Grujić M; Obradov S; Perinović M; Rizvanbegović B
    Med Arh; 1976; 30(5):327-30. PubMed ID: 798077
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sudden deafness: apropos of 19 cases. Results of treatment with pentoxifylline. Value of erythrocyte filtration time].
    Denis F; Ketari M; Benzaken J; Renou G
    Ann Otolaryngol Chir Cervicofac; 1989; 106(1):21-6. PubMed ID: 2719437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.